The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope
- PMID: 9326323
- PMCID: PMC1715943
- DOI: 10.1086/515518
The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope
Abstract
The erythrokeratodermas (EKs) are a group of disorders characterized by erythematous plaques associated with variable features that include palmoplantar keratoderma. One type of EK is known as "progressive symmetric erythrokeratoderma" (PSEK). We studied members of a family of Japanese origin in which the index case with PSEK had had well-demarcated nonmigratory erythematous plaques on her extremities since birth. Sequence determination of the loricrin gene revealed an insertion of a C following nucleotide 709. The mutation results in a frameshift that changes the terminal 91 amino acids in the wild-type polypeptide into missense amino acids and adds 65 additional residues. This further implicates loricrin defects in the pathogenesis of disorders with palmoplantar keratoderma and pseudoainhum.
Similar articles
-
Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma.J Cell Biol. 2000 Oct 16;151(2):401-12. doi: 10.1083/jcb.151.2.401. J Cell Biol. 2000. PMID: 11038186 Free PMC article.
-
Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings.Br J Dermatol. 1991 May;124(5):487-91. doi: 10.1111/j.1365-2133.1991.tb00632.x. Br J Dermatol. 1991. PMID: 1828175
-
Abnormal cornified cell envelope formation in mutilating palmoplantar keratoderma unrelated to epidermal differentiation complex.J Invest Dermatol. 1998 Jul;111(1):133-8. doi: 10.1046/j.1523-1747.1998.00230.x. J Invest Dermatol. 1998. PMID: 9665400
-
Loricrin and human skin diseases: molecular basis of loricrin keratodermas.Histol Histopathol. 1998 Jul;13(3):819-26. doi: 10.14670/HH-13.819. Histol Histopathol. 1998. PMID: 9690138 Review.
-
Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin.J Dermatol Sci. 2003 Feb;31(1):3-8. doi: 10.1016/s0923-1811(02)00143-3. J Dermatol Sci. 2003. PMID: 12615358 Review.
Cited by
-
Loricrin at the Boundary between Inside and Outside.Biomolecules. 2022 May 6;12(5):673. doi: 10.3390/biom12050673. Biomolecules. 2022. PMID: 35625601 Free PMC article. Review.
-
Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype.J Invest Dermatol. 2015 Jan;135(1):170-180. doi: 10.1038/jid.2014.310. Epub 2014 Aug 22. J Invest Dermatol. 2015. PMID: 25050598 Free PMC article.
-
Loricrin: Past, Present, and Future.Int J Mol Sci. 2020 Mar 25;21(7):2271. doi: 10.3390/ijms21072271. Int J Mol Sci. 2020. PMID: 32218335 Free PMC article. Review.
-
TRPV3 mutants causing Olmsted Syndrome induce impaired cell adhesion and nonfunctional lysosomes.Channels (Austin). 2017 May 4;11(3):196-208. doi: 10.1080/19336950.2016.1249076. Epub 2016 Oct 18. Channels (Austin). 2017. PMID: 27754757 Free PMC article.
-
Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein.J Cell Biol. 2000 Oct 16;151(2):389-400. doi: 10.1083/jcb.151.2.389. J Cell Biol. 2000. PMID: 11038185 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials